Clinical Trials
9 trialsNCT02311959 2026-04-14
MAPAM-01
Institut Claudius Regaud
Phase 3 Completed
NCT07480356 2026-03-18
ADVANCED-3
Protara Therapeutics
Phase 3 Not yet recruiting
NCT04452591 2026-03-16
BOND-003
CG Oncology, Inc.
Phase 3 Active not recruiting
NCT03223753 2025-04-18
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer
Children's Oncology Group
Phase 3 Active not recruiting
NCT00402779 2020-04-21
Erlotinib Prevention of Oral Cancer (EPOC)
M.D. Anderson Cancer Center
Phase 3 Completed
NCT02471495 2018-05-07
RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)
Medical Enterprises Europe B.V.
Phase 3 Withdrawn
NCT01310803 2017-10-05
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder
Endo Pharmaceuticals
Phase 3 Terminated
NCT01200992 2017-08-24
EMBARC-RF
Bioniche Life Sciences Inc.
Phase 3 Terminated
NCT00352404 2006-07-14
Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia
Johannes Gutenberg University Mainz
Phase 3 Completed